Trial intelligence / Profile preview

Bio-Ceramic vs Calcium Hydroxide Intracanal Medication in Diabetic Patients

NCT07071675Not yet recruiting

Sponsor
Minia University
Start
Sep 2025
Primary completion
Aug 2026
01

Overview

Randomised trial in pulp necrosis (2 arms), sponsored by Minia University. Primary endpoints: Postoperative Pain Intensity at 7 days and Flare-Up Incidence at 7 days. Planned start Sep 2025; status: not yet recruiting.

02

Conditions

pulp necrosis

Beyond the preview

Go deeper on NCT07071675.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07071675.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call